1.29
price up icon0.78%   0.01
after-market Dopo l'orario di chiusura: 1.25 -0.04 -3.10%
loading
Precedente Chiudi:
$1.28
Aprire:
$1.27
Volume 24 ore:
56,429
Relative Volume:
0.58
Capitalizzazione di mercato:
$66.37M
Reddito:
$33.79M
Utile/perdita netta:
$-18.67M
Rapporto P/E:
-3.6013
EPS:
-0.3582
Flusso di cassa netto:
$-19.17M
1 W Prestazione:
+7.50%
1M Prestazione:
+53.57%
6M Prestazione:
+41.76%
1 anno Prestazione:
+84.29%
Intervallo 1D:
Value
$1.2523
$1.30
Intervallo di 1 settimana:
Value
$1.10
$1.30
Portata 52W:
Value
$0.7101
$1.61

Cytosorbents Corp Stock (CTSO) Company Profile

Name
Nome
Cytosorbents Corp
Name
Telefono
973-329-8885
Name
Indirizzo
305 COLLEGE ROAD EAST, PRINCETON, NJ
Name
Dipendente
149
Name
Cinguettio
@CytoSorbents
Name
Prossima data di guadagno
2025-03-31
Name
Ultimi documenti SEC
Name
CTSO's Discussions on Twitter

Confronta CTSO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Devices icon
CTSO
Cytosorbents Corp
1.29 66.37M 33.79M -18.67M -19.17M -0.3582
Medical Devices icon
ABT
Abbott Laboratories
136.26 233.36B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
BSX
Boston Scientific Corp
104.78 147.06B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
396.74 145.64B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
88.75 112.76B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
77.18 44.46B 5.54B 4.18B 623.10M 7.00

Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-09-07 Iniziato B. Riley Securities Buy
2021-10-14 Ripresa B. Riley Securities Buy
2020-09-17 Iniziato Jefferies Buy
2020-09-01 Iniziato SVB Leerink Outperform
2017-08-08 Reiterato Maxim Group Buy
2016-10-26 Iniziato Aegis Capital Buy
2016-05-24 Iniziato Maxim Group Buy
2015-10-29 Aggiornamento WBB Securities Speculative Buy → Buy
2015-05-12 Reiterato MLV & Co Buy
2015-04-01 Reiterato MLV & Co Buy
2015-03-05 Iniziato MLV & Co Buy
2015-02-25 Iniziato WBB Securities Speculative Buy
2015-01-27 Reiterato H.C. Wainwright Buy
Mostra tutto

Cytosorbents Corp Borsa (CTSO) Ultime notizie

pulisher
Jun 15, 2025

Millennium Management LLC Buys Shares of 33,280 Cytosorbents Co. (NASDAQ:CTSO) - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

Cytosorbents announces voting results from annual meeting By Investing.com - Investing.com Canada

Jun 13, 2025
pulisher
Jun 13, 2025

Cytosorbents announces voting results from annual meeting - Investing.com

Jun 13, 2025
pulisher
Jun 11, 2025

CytoSorbents Warrants Expire Worthless as Stock Price Fails Threshold - Investing.com

Jun 11, 2025
pulisher
Jun 04, 2025

Cytosorbents Co. (NASDAQ:CTSO) Shares Purchased by Northern Trust Corp - Defense World

Jun 04, 2025
pulisher
May 29, 2025

Critical Care Leader CytoSorbents Reveals Growth Strategy at Jefferies Healthcare Conference - Stock Titan

May 29, 2025
pulisher
May 22, 2025

Cytosorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented At EuroPCR 2025 - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

CytoSorbents device cuts bleeding in CABG patients - Investing.com

May 22, 2025
pulisher
May 22, 2025

New Clinical Data: How CytoSorbents' Breakthrough Device Slashes Severe Bleeding Risk in Urgent Heart Surgery - Stock Titan

May 22, 2025
pulisher
May 21, 2025

Cytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at StockNews.com - Defense World

May 21, 2025
pulisher
May 19, 2025

Cytosorbents FY2025 EPS Forecast Lifted by HC Wainwright - Defense World

May 19, 2025
pulisher
May 17, 2025

D. Boral Capital Reiterates “Buy” Rating for Cytosorbents (NASDAQ:CTSO) - Defense World

May 17, 2025
pulisher
May 17, 2025

Cytosorbents (NASDAQ:CTSO) Earns Neutral Rating from HC Wainwright - Defense World

May 17, 2025
pulisher
May 16, 2025

Cytosorbents Corporation (NASDAQ:CTSO) Q1 2025 Earnings Call Transcript - Insider Monkey

May 16, 2025
pulisher
May 15, 2025

Cytosorbents Corp’s Earnings Call: A Balanced Outlook - TipRanks

May 15, 2025
pulisher
May 15, 2025

CytoSorbents (CTSO) Receives Neutral Rating from HC Wainwright & Co. | CTSO Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

CytoSorbents (CTSO) Maintains Buy Rating with $10 Price Target | - GuruFocus

May 15, 2025
pulisher
May 15, 2025

CytoSorbents (CTSO) Maintains Buy Rating with $10 Price Target | CTSO Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

CytoSorbents: Q1 Earnings Snapshot - CT Insider

May 15, 2025
pulisher
May 15, 2025

CytoSorbents Corp (CTSO) Q1 2025 Earnings Call Highlights: Navigating Challenges and ... - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

CytoSorbents Corp (CTSO) Q1 2025 Earnings Call Highlights: Navigating Challenges and Strengthening Financials - GuruFocus

May 15, 2025
pulisher
May 15, 2025

StockNews.com Initiates Coverage on Cytosorbents (NASDAQ:CTSO) - Defense World

May 15, 2025
pulisher
May 14, 2025

CytoSorbents (CTSO) Targets Growth Amid Regulatory Challenges - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Earnings call transcript: CytoSorbents Q1 2025 misses earnings, stock dips - Investing.com

May 14, 2025
pulisher
May 14, 2025

CytoSorbents Corp Q1 2025 Earnings: EPS of -$0.06 Beats Estimate, Revenue of $8.7M Misses Estimate - GuruFocus

May 14, 2025
pulisher
May 14, 2025

CTSO Reports Q1 Revenue Below Expectations Amid Strategic Changes in Germany | CTSO Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

CytoSorbents Corporation Q1 2025 Financial Results - TradingView

May 14, 2025
pulisher
May 14, 2025

CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update - PR Newswire

May 14, 2025
pulisher
May 14, 2025

Transcript : Cytosorbents Corporation, Q1 2025 Earnings Call, May 14, 2025 - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Raymond James Financial Inc. Makes New Investment in Cytosorbents Co. (NASDAQ:CTSO) - Defense World

May 14, 2025
pulisher
May 13, 2025

CytoSorbents Corp (CTSO) Q1 2025 Earnings Report Preview: What t - GuruFocus

May 13, 2025
pulisher
May 13, 2025

CytoSorbents's Earnings: A Preview - Nasdaq

May 13, 2025
pulisher
May 13, 2025

CytoSorbents Corp (CTSO) Q1 2025 Earnings Report Preview: What to Look For - GuruFocus

May 13, 2025
pulisher
May 07, 2025

Cytosorbents (CTSO) Projected to Post Earnings on Wednesday - Defense World

May 07, 2025
pulisher
May 05, 2025

Cytosorbents’ (CTSO) “Buy” Rating Reiterated at D. Boral Capital - Defense World

May 05, 2025
pulisher
May 05, 2025

Cytosorbents (NASDAQ:CTSO) Coverage Initiated at StockNews.com - Defense World

May 05, 2025
pulisher
May 02, 2025

CytoSorbents (CTSO) Stock: Analyst Maintains "Buy" Rating with $ - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Behind Cytosorbents Corp’s 52-Week Range: Uncovering Opportunities for Investors - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Today’s watch list includes Cytosorbents Corp (NASDAQ:CTSO) stock - uspostnews.com

May 02, 2025
pulisher
May 02, 2025

CytoSorbents (CTSO) Stock: Analyst Maintains - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Demystifying CytoSorbents: Insights From 4 Analyst Reviews - Benzinga

May 02, 2025
pulisher
May 02, 2025

FDA denies CytoSorbents’ request for DrugSorb-ATR device - Investing.com

May 02, 2025
pulisher
May 02, 2025

CytoSorbents: FDA issues denial letter for De Novo Request for DrugSorb-ATR - TipRanks

May 02, 2025
pulisher
May 01, 2025

CytoSorbents (CTSO) Awaits FDA Approval for Breakthrough Device DrugSorb-ATR | CTSO Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

CytoSorbents Provides Regulatory Update for DrugSorb-ATR - PR Newswire

May 01, 2025
pulisher
May 01, 2025

Cytosorbents (NASDAQ:CTSO) versus Microbot Medical (NASDAQ:MBOT) Financial Analysis - Defense World

May 01, 2025
pulisher
Apr 30, 2025

CytoSorbents to Report First Quarter 2025 Financial Results and Recent Business Highlights - Longview News-Journal

Apr 30, 2025
pulisher
Apr 29, 2025

CytoSorbents, Blood Purification Leader, Reveals Q1 2025 Results and Business Updates May 14 - Stock Titan

Apr 29, 2025
pulisher
Apr 21, 2025

CytoSorbents secures $1.7M via NJ tax credit transfer - Investing.com

Apr 21, 2025
pulisher
Apr 21, 2025

CytoSorbents Lands $1.7M Strategic Funding: New DrugSorb Product Launch and Manufacturing Expansion Ahead - Stock Titan

Apr 21, 2025
pulisher
Apr 20, 2025

U.S. FDA Grants Breakthrough Designation To Cytosorb For Removal Of Ticagrelor During Cardiopulmonary Bypass In Emergent And Urgent Cardiothoracic Surgery - Reuters

Apr 20, 2025

Cytosorbents Corp Azioni (CTSO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Cytosorbents Corp Azioni (CTSO) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
MARIANI PETER J
Chief Financial Officer
Dec 12 '24
Buy
0.89
20,000
17,872
381,363
MARIANI PETER J
Chief Financial Officer
Dec 11 '24
Buy
0.89
11,363
10,103
361,363
$299.99
price down icon 4.52%
medical_devices PHG
$24.20
price up icon 0.92%
medical_devices STE
$242.66
price up icon 1.02%
$83.58
price down icon 4.25%
$75.95
price up icon 2.54%
medical_devices EW
$77.18
price down icon 1.32%
Capitalizzazione:     |  Volume (24 ore):